Format

Send to

Choose Destination
Curr Opin Drug Discov Devel. 2010 Jan;13(1):66-77.

The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.

Author information

1
University of Washington, Department of Medicinal Chemistry, Box 357610, Seattle, WA 98195, USA.

Abstract

The irreversible inhibition of cytochrome P450 (CYP) enzymes can cause significant drug-drug interactions (DDIs). The formation of metabolites is fundamental for the inactivation of CYP enzymes. Of the 19 CYP enzyme inactivators for which the mechanism of action has been established, 10 have circulating metabolites, which are on the metabolic pathway to inactivation of the CYP enzyme. Because inactivation of CYP enzymes usually requires multiple metabolic steps, the prediction of interactions between metabolites and CYPs in vivo may require complex models and the availability of data generated in vitro from each metabolite. Data discussed in this review suggest that circulating metabolites are more important in CYP inhibition in vivo than has been acknowledged.

PMID:
20047147
PMCID:
PMC2898504
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center